PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications
申请人:Centre National de la Recherche Scientifique
(CNRS)
公开号:EP2845588A1
公开(公告)日:2015-03-11
The present invention relates to the field of lymphoproliferative Theileriosis, and more particularly to peptidyl-prolyl cis/trans isomerase 1 (PIN1) inhibitors for their use in the prevention and/or treatment of lymphoproliferative Theileriosis. The invention further encompasses screening, diagnostic and therapeutic methods, as well as to kits useful for carrying out said methods.
本发明涉及淋巴细胞增生性肉芽肿病领域,尤其是肽基脯氨酰顺式/反式异构酶1(PIN1)抑制剂,用于预防和/或治疗淋巴细胞增生性肉芽肿病。本发明还包括筛选、诊断和治疗方法,以及用于实施上述方法的试剂盒。